European ombudsman Nikiforos Diamandouros has called on the European Medicines Agency (EMA) to grant access to clinical study reports and trial protocols for anti-obesity drugs. His demand follows a complaint from Danish healthcare researchers who wanted to conduct an independent analysis of the drugs. In 2007, the researchers, from a health and information centre, asked to see clinical study reports and corresponding trial protocols for two anti-obesity drugs. They explained that they wanted to conduct an independent analysis given that, in their view, biased reporting on drug trials was common.
Read article at theparliament.com
Friday, June 18, 2010
European Medicines Agency told to provide details on anti-obesity drugs
Subscribe to:
var sc_project=1725605;
var sc_invisible=0;
var sc_partition=16;
var sc_security="acf71b9a";